PINK:NYE-Simplify Exchange Traded Funds - Simplify Health Care ETF (USD)

ETF | Others |

Last Closing

USD 29.67

Change

+0.05 (+0.17)%

Market Cap

USD 0.12B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE SOJE

N/A

USD 65.72B
JEPI JPMorgan Equity Premium Income..

N/A

USD 33.68B
DFAC Dimensional U.S. Core Equity 2..

N/A

USD 27.49B
DTB DTB

N/A

USD 26.58B
GBTC Grayscale Bitcoin Trust (BTC)

N/A

USD 23.75B
JPST JPMorgan Ultra-Short Income ET..

N/A

USD 23.09B
SGOV iShares® 0-3 Month Treasury B..

N/A

USD 20.81B
AVUV Avantis® U.S. Small Cap Value..

N/A

USD 11.25B
DFUV Dimensional US Marketwide Valu..

N/A

USD 10.54B
DFAT Dimensional U.S. Targeted Valu..

N/A

USD 9.93B

ETFs Containing PINK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.52% 80% B- 74% C
Dividend Return 0.11% 5% F 4% F
Total Return 8.63% 79% B- 72% C
Trailing 12 Months  
Capital Gain 14.03% 60% D- 62% D
Dividend Return 1.04% 17% F 12% F
Total Return 15.07% 58% F 57% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.07% 63% D 49% F
Dividend Return 2.37% 58% F 39% F
Total Return 0.29% 21% F 7% C-
Risk Return Profile  
Volatility (Standard Deviation) 7.01% 63% D 87% B+
Risk Adjusted Return 33.74% 58% F 56% F
Market Capitalization 0.12B 66% D+ 27% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.